脱发治疗(脱发)市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

脱发治疗(脱发)市场按疾病类型、性别(男性和女性)、给药途径、分销渠道和地理区域划分

市场快照

Alopecia Treatment Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.2 %
Alopecia Treatment Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

脱发是一个术语,用于描述在某些医疗条件或饮食问题下过度的头发损伤。久坐不动的生活方式和不健康的饮食导致大众脱发。此外,衰老和荷尔蒙失调,关节炎、癌症、高血压、抑郁等慢性疾病的增加也会导致脱发,尤其是在中年人群中。根据美国脱发协会的数据,雄激素性脱发占男性脱发的 95% 以上。全世界有超过 80 万患者正在寻求某种脱发治疗方法。

近年来,许多治疗脱发的新药已获得监管机构的批准,许多药物正在筹备中,预计将在不久的将来获得批准。Concert Pharmaceuticals Inc. 于 2018 年 1 月获得美国食品药品监督管理局 (FDA) 的快速通道指定,用于治疗中度至重度斑秃的新产品。预计此类新产品将在市场上推出在不久的将来推动全球脱发治疗市场的增长。

报告范围

根据报告的范围,脱发治疗(脱发)是用于治疗脱发的药物。涵盖用于治疗脱发的脱发治疗(脱发)药物,如米诺地尔、非那雄胺和环孢菌素。脱发也称为脱发或秃顶,是一种医疗状况,指的是头部或身体任何部位的头发脱落。​​​

By Disease Type
Androgenic Alopecia
Alopecia Areata
Ciatricial Alopecia
Traction Alopecia
Alopecia Totalis
By Gender
Male
Female
By Route of Administration
Oral
Topical
Injectable
By Distribution Channel
Hospitals
Retail Pharmacies
Online Pharmacies
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

预计女性将在预测期内持有最大份额

大约三分之一的女性在一生中的某个时候经历过脱发(脱发)。在绝经后妇女中,多达三分之二的人患有头发稀疏或秃斑。女性脱发通常比男性脱发的影响更大,因为她们在社会上不太容易接受。 

雄激素性脱发是女性脱发的最常见原因。脱发会严重影响女性的情绪健康和生活质量。虽然脱发在男性中比女性更常见,但女性在市场上的份额最大,原因是意识水平高,再加上多囊卵巢综合征 (PCOS) 的频率增加,导致荷尔蒙失调导致雄激素性脱发。

Alopecia Treatment Market Trends

北美地区拥有最大的脱发治疗(脱发)市场份额

由于技术先进的医疗保健基础设施、高可支配收入以及与治疗相关的新型治疗选择的可用性,北美在脱发治疗(脱发)市场占据主导地位。根据美国国家医学图书馆的数据,斑秃影响美国每 500 至 1,000 人中的 1 人。它是许多公认的脱发形式之一,斑秃是继雄激素性脱发之后的第二常见形式。斑秃对男性和女性的影响是平等的,它可以发生在任何种族背景的人身上。因此,美国脱发的高患病率和相应的高治疗率是北美市场的主要驱动力。

Alopecia Treatment Market Outlook

竞争格局

在整个脱发治疗(脱发)市场运营的一些著名行业参与者包括 Sun Pharmaceuticals Industries Ltd.、Aclaris Therapeutics Inc.、Cipla Inc.、Concert Pharmaceuticals Inc.、Daiichi Sankyo Inc.。严谨的营销是市场参与者采用的竞争策略之一。2018 年,生物技术公司 HCell Inc. 的产品获得了 FDA 的孤儿药指定 (ODD)。此外,2017 年,Perrigo Company PLC。推出非处方女士落健,有助于头皮上的头发再生。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Alopecia

      2. 4.2.2 Increasing R&D Initiatives and New Product Launches and Approvals

    3. 4.3 Market Restraints

      1. 4.3.1 Patent Expiry of Many Blockbuster Drugs

      2. 4.3.2 Side Effects Associated with the Available Hair Loss Treatment Therapies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Disease Type

      1. 5.1.1 Androgenic Alopecia

      2. 5.1.2 Alopecia Areata

      3. 5.1.3 Ciatricial Alopecia

      4. 5.1.4 Traction Alopecia

      5. 5.1.5 Alopecia Totalis

    2. 5.2 By Gender

      1. 5.2.1 Male

      2. 5.2.2 Female

    3. 5.3 By Route of Administration

      1. 5.3.1 Oral

      2. 5.3.2 Topical

      3. 5.3.3 Injectable

    4. 5.4 By Distribution Channel

      1. 5.4.1 Hospitals

      2. 5.4.2 Retail Pharmacies

      3. 5.4.3 Online Pharmacies

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Middle-East and Africa

        1. 5.5.4.1 GCC

        2. 5.5.4.2 South Africa

        3. 5.5.4.3 Rest of Middle-East and Africa

      5. 5.5.5 South America

        1. 5.5.5.1 Brazil

        2. 5.5.5.2 Argentina

        3. 5.5.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Aclaris Therapeutics Inc.

      2. 6.1.2 Cipla Inc.

      3. 6.1.3 Concert Pharmaceuticals Inc.

      4. 6.1.4 Daiichi Sankyo Inc.

      5. 6.1.5 GlaxoSmithKline PLC

      6. 6.1.6 HCell Inc.

      7. 6.1.7 Johnson & Johnson

      8. 6.1.8 Merck & Co. Inc.

      9. 6.1.9 Sun Pharmaceuticals Industries Ltd

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Alopecia Treatment (Hair Loss) Market market is studied from 2018 - 2026.

The Alopecia Treatment (Hair Loss) Market is growing at a CAGR of 5.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Sun Pharmaceuticals Industries Ltd., Johnson & Johnson, Concert Pharmaceuticals Inc., Cipla Inc., Daiichi Sankyo are the major companies operating in Alopecia Treatment (Hair Loss) Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!